← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Immuno-Mycologics, Inc.
Norman, OK
$5,986,752
Total funding
7
Grants
Funding over time
peak $1.5M · FY2011–22$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,986,752 · 7
By mechanism
R44$1,819,658 · 1
R41$1,781,289 · 3
N01$1,499,709 · 1
R43$586,503 · 1
N43$299,593 · 1
Investigators at Immuno-Mycologics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of rapid fungal diagnostics for select endemic dimorphic fungi$1,499,709
N01 · FY2022 · AI
Lateral Flow Assay for Diagnosis of Histoplasmosis$972,745
R44 · FY2015 · AI
Lateral Flow Assay for Diagnosis of Histoplasmosis$846,913
R44 · FY2016 · AI
Immunoassay for diagnosis of invasive fungal disease$300,000
R41 · FY2013 · AI
Immunoassay for diagnosis of invasive fungal disease$300,000
R41 · FY2014 · AI
Point-of-care immunoassay for diagnosis of histoplasmosis in HIV/AIDS$299,712
R41 · FY2011 · AI
Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay$299,640
R41 · FY2014 · AI
DEVELOPMENT AN EASY-TO-USE DIAGNOSTIC TEST CAPABLE OF EARLY, RAPID DETECTION OF FUNGAL INFECTIONS$299,593
N43 · FY2020 · AI
Antigen Immunoassay for Diagnosis of Coccidioidomycosis$295,438
R43 · FY2012 · AI
Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay$292,900
R41 · FY2015 · AI
Antigen Immunoassay for Diagnosis of Coccidioidomycosis$291,065
R43 · FY2013 · AI
Point-of-care immunoassay for diagnosis of histoplasmosis in HIV/AIDS$289,037
R41 · FY2012 · AI